Evidence map›Paper›PMID 33326239›Full record

ArticleJournal of chemical information and modeling2020

Supercomputer-Based Ensemble Docking Drug Discovery Pipeline with Application to Covid-19.

A Acharya, R Agarwal, M B Baker, J Baudry, D Bhowmik, S Boehm, K G Byler, S Y Chen, L Coates, C J Cooper and 41 more

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Gradient Descent to Predict Enzyme Inhibition.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Profiling and cheminformatics bioprospection of curcurbitacin I and momordin Ic fromJournal of enzyme inhibition and medicinal chemistry · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

51 authors.

A AcharyaSchool of Physics, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.ORCID 0000-0002-6960-7789
R AgarwalUT/ORNL Center for Molecular Biophysics, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, United States.ORCID 0000-0003-1029-2281
M B BakerComputer Science and Mathematics Division, Oak Ridge National Lab, Oak Ridge, Tennessee 37830, United States.
J BaudryThe University of Alabama in Huntsville, Department of Biological Sciences. 301 Sparkman Drive, Huntsville, Alabama 35899, United States.ORCID 0000-0002-1969-1679
D BhowmikComputational Sciences and Engineering Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, United States.ORCID 0000-0001-7770-9091
S BoehmComputer Science and Mathematics Division, Oak Ridge National Lab, Oak Ridge, Tennessee 37830, United States.
K G BylerThe University of Alabama in Huntsville, Department of Biological Sciences. 301 Sparkman Drive, Huntsville, Alabama 35899, United States.
S Y ChenComputational Science Initiative, Brookhaven National Laboratory, Upton, New York 11973, United States.
L CoatesNeutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, United States.ORCID 0000-0003-2342-049X
C J CooperUT/ORNL Center for Molecular Biophysics, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, United States.ORCID 0000-0002-5527-9948
O DemerdashBiosciences Division, Oak Ridge National Lab, Oak Ridge, Tennessee 37830, United States.
I DaidoneDepartment of Physical and Chemical Sciences, University of L'Aquila, I-67010 L'Aquila, Italy.ORCID 0000-0001-8970-8408
J D EblenUT/ORNL Center for Molecular Biophysics, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, United States.
S EllingsonUniversity of Kentucky, Division of Biomedical Informatics, College of Medicine, UK Medical Center MN 150, Lexington Kentucky 40536, United States.
S ForliScripps Research, La Jolla, California 92037, United States.ORCID 0000-0002-5964-7111
J GlaserNational Center for Computational Sciences, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, United States.
J C GumbartSchool of Physics, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.ORCID 0000-0002-1510-7842
J GunnelsHPC Engineering, Amazon Web Services, Seattle, Washington 98121, United States.
O HernandezComputer Science and Mathematics Division, Oak Ridge National Lab, Oak Ridge, Tennessee 37830, United States.
S IrleComputational Sciences and Engineering Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, United States.ORCID 0000-0003-4995-4991
D W KnellerNeutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, United States.
A KovalevskyNeutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, United States.ORCID 0000-0003-4459-9142
J LarkinNVIDIA Corporation, Santa Clara, California 95051, United States.
T J LawrenceBiosciences Division, Oak Ridge National Lab, Oak Ridge, Tennessee 37830, United States.
S LeGrandNVIDIA Corporation, Santa Clara, California 95051, United States.
S-H LiuUT/ORNL Center for Molecular Biophysics, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, United States.ORCID 0000-0002-8889-1375
J C MitchellBiosciences Division, Oak Ridge National Lab, Oak Ridge, Tennessee 37830, United States.
G ParkComputational Science Initiative, Brookhaven National Laboratory, Upton, New York 11973, United States.
J M ParksUT/ORNL Center for Molecular Biophysics, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, United States.ORCID 0000-0002-3103-9333
A PavlovaSchool of Physics, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
L PetridisUT/ORNL Center for Molecular Biophysics, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, United States.ORCID 0000-0001-8569-060X
D PooleNVIDIA Corporation, Santa Clara, California 95051, United States.
L PouchardComputational Science Initiative, Brookhaven National Laboratory, Upton, New York 11973, United States.
A RamanathanData Science and Learning Division, Argonne National Lab, Lemont, Illinois 60439, United States.
D M RogersNational Center for Computational Sciences, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, United States.ORCID 0000-0002-5187-1768
D Santos-MartinsScripps Research, La Jolla, California 92037, United States.
A ScheinbergJubilee Development, Cambridge Massachusetts 02139, United States.
A SedovaBiosciences Division, Oak Ridge National Lab, Oak Ridge, Tennessee 37830, United States.ORCID 0000-0002-8233-3057
Y ShenUT/ORNL Center for Molecular Biophysics, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, United States.
J C SmithUT/ORNL Center for Molecular Biophysics, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, United States.ORCID 0000-0002-2978-3227
M D SmithUT/ORNL Center for Molecular Biophysics, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, United States.ORCID 0000-0002-0777-7539
C SotoComputational Science Initiative, Brookhaven National Laboratory, Upton, New York 11973, United States.
A TsarisNational Center for Computational Sciences, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, United States.
M ThavappiragasamBiosciences Division, Oak Ridge National Lab, Oak Ridge, Tennessee 37830, United States.
A F TillackScripps Research, La Jolla, California 92037, United States.
J V VermaasNational Center for Computational Sciences, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, United States.ORCID 0000-0003-3139-6469
V Q VuongComputational Sciences and Engineering Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, United States.
J YinNational Center for Computational Sciences, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, United States.
S YooComputational Science Initiative, Brookhaven National Laboratory, Upton, New York 11973, United States.
M ZahranDepartment of Biological Sciences, New York City College of Technology, The City University of New York (CUNY), Brooklyn, New York 11201, United States.
L Zanetti-PolziCNR Institute of Nanoscience, I-41125 Modena, Italy.ORCID 0000-0002-2550-4796

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers · 2013 to 2026
$38.3M
Altering Hepatitis B Virus assembly through pharmacological interventionR01AI148740 · NIAID · GEORGIA INSTITUTE OF TECHNOLOGY · PI GUMBART, JAMES C. · 2020 to 2024
$2.0M
NCI NIH HHS P30 CA177558NIAID NIH HHS R01 AI148740
6 · The paper itself

Abstract

We present a supercomputer-driven pipeline for in silico drug discovery using enhanced sampling molecular dynamics (MD) and ensemble docking. Ensemble docking makes use of MD results by docking compound databases into representative protein binding-site conformations, thus taking into account the dynamic properties of the binding sites. We also describe preliminary results obtained for 24 systems involving eight proteins of the proteome of SARS-CoV-2. The MD involves temperature replica exchange enhanced sampling, making use of massively parallel supercomputing to quickly sample the configurational space of protein drug targets. Using the Summit supercomputer at the Oak Ridge National Laboratory, more than 1 ms of enhanced sampling MD can be generated per day. We have ensemble docked repurposing databases to 10 configurations of each of the 24 SARS-CoV-2 systems using AutoDock Vina. Comparison to experiment demonstrates remarkably high hit rates for the top scoring tranches of compounds identified by our ensemble approach. We also demonstrate that, using Autodock-GPU on Summit, it is possible to perform exhaustive docking of one billion compounds in under 24 h. Finally, we discuss preliminary results and planned improvements to the pipeline, including the use of quantum mechanical (QM), machine learning, and artificial intelligence (AI) methods to cluster MD trajectories and rescore docking poses.

Indexed as

COVID-19 Drug TreatmentAntiviral AgentsArtificial IntelligenceBinding SitesComputer SimulationDatabases, ChemicalDrug DesignDrug Evaluation, PreclinicalHumansMolecular Docking SimulationProtein ConformationSARS-CoV-2Spike Glycoprotein, CoronavirusStructure-Activity RelationshipViral Nonstructural ProteinsAntiviral AgentsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Viral Nonstructural Proteins

Identifiers

PMID33326239
PMCPMC7754786

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.